Back to search

Article

Increases in <i>BCL2L1</i> and <i>ID1</i> dosage synergistically drive fate bias and competitive advantage in human pluripotent stem cells

2026-03-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Gains of chromosome 20q11.21 are among the most common culture-acquired abnormalities in human pluripotent stem cells (hPSC), conferring a well-defined survival advantage while altering differentiation capacity. However, it remains unclear whether this advantage persists during differentiation, how the aneuploidy alters ectodermal and retinal pigment epithelium (RPE) lineage...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d0ef238-553e-5a5e-8a10-b51cb1821d4a
DOI
10.64898/2026.03.26.714405
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Increases in <i>BCL2L1</i> and <i>ID1</i> dosage synergistically drive fate bias and competitive advantage in human pluripotent stem cellsDOI 10.64898/2026.03.26.714405
Select a neighboring publication to make it the new centre.